Leading Viral Vector CDMO Services for Cell and Gene Therapies


With more than 14 years of experience in viral vector services, Patheon is your end-to-end viral vector CDMO partner from process and analytical development to clinical and commercial supply of viral vectors for your cell or gene therapy or vaccine. We enable emerging biotech and large pharma to deliver breakthrough medicines to patients by unleashing the potential of cell and gene therapy.

Download this brochure to learn more about our end-to-end viral vector service capabilities.